Short Takes: Tips for Corrected Claims, Annual Fee Schedule, and More

Tips for Submitting Corrected Claims

It is important to file a corrected claim accurately to ensure that Highmark can identify the original claim, understand the correction that is required, and ensure that the corrected claim is not denied as a duplicate.

To reduce errors and possible rejection of your claim resubmission, please follow the guidelines listed in this Special Bulletin.


Annual Fee Schedule Update Will Occur on Nov. 1, 2024

Our annual fee schedule update for commercial and Medicare Advantage products in our New York regions will take effect on Nov. 1, 2024. Updates include some incremental increases and decreases throughout the fee schedule to align with Highmark’s fee schedules. Learn more here.

August is National Immunization Awareness Month (NIAM)

NIAM is an excellent time for not only communicating the importance of routine vaccinations, but also for reviewing... Click here to read more.


Annual Phone Survey to Verify Provider Directory Information

Throughout August, the independent research firm Press Ganey will conduct phone surveys with a sampling of providers in Delaware, New York, Pennsylvania, and West Virginia. Survey questions will assess knowledge of the tools available to you and your staff and to verify the products/networks in which you participate through your Highmark contract. To learn more, click here.


Express Scripts Pharmacy to No Longer Stock a Limited Set of Medications

Effective Aug. 19, 2024, Express Scripts Pharmacy is no longer stocking a limited set of medications for all lines of business. Members currently receiving impacted drugs have the option to fill an alternative drug at Express Script home delivery, but those who want to or need to continue filling the impacted drugs will need to do so from an alternative, in-network retail pharmacy. For more information and to see the list of impacted medications, click here.


Farxiga Added to Medicare Formularies as a Tier 3 Preferred Brand Name

As of Aug. 1, 2024, Highmark has added Farxiga to its Medicare formularies as a Tier 3 Preferred Brand Name Drug. This change will help to reduce prescription drug costs for our members. To read the Special Bulletin, go here.


Professional Providers: Sign and Return Group Contracts

Highmark Blue Cross Blue Shield is beginning the process of moving professional providers in its New York markets onto Highmark Professional Agreements. Group agreements will reduce the administrative burden of requiring each practitioner to sign an individual contract. Instead, the practice will sign for all participating practitioners. Once your office receives your group contract, we ask that you sign it and send it back promptly.


Highmark Expands Free Market Health to Our Pharmacy Market in New York

Beginning August 2024, Highmark will welcome Free Market Health (FMH) into our pharmacy market in our New York regions:

  • Highmark Blue Cross Blue Shield (WNY)
  • Highmark Blue Shield (NENY)

Free Market Health’s care driven marketplace seamlessly connects members to a curated selection of high-quality specialty pharmacies. FMH's technology platform enables us to make sure our members receive the most clinically appropriate care at the most competitive pricing. To learn more, click here.


 

esubscribe